title: Estimating the impact of alcohol consumption on survival for HIV+ individuals.
abstract: Alcohol consumption is associated with decreased antiretroviral adherence, and decreased adherence results in poorer outcomes. However the magnitude of alcohol's impact on survival is unknown. Our objective was to use a calibrated and validated simulation of HIV disease to estimate the impact of alcohol on survival. We incorporated clinical data describing the temporal and dose-response relationships between alcohol consumption and adherence in a large observational cohort (N=2,702). Individuals were categorized as nondrinkers (no alcohol consumption), hazardous drinkers (consume > or =5 standard drinks on drinking days), and nonhazardous drinkers (consume <5 standard drinks on drinking days). Our results showed that nonhazardous alcohol consumption decreased survival by more than 1 year if the frequency of consumption was once per week or greater, and by 3.3 years (from 21.7 years to 18.4 years) with daily consumption. Hazardous alcohol consumption decreased overall survival by more than 3 years if frequency of consumption was once per week or greater, and by 6.4 years (From 16.1 years to 9.7 years) with daily consumption. Our results suggest that alcohol is an underappreciated yet modifiable risk factor for poor survival among individuals with HIV.
authors: Yale University School of Medicine, West Haven, CT, USA.
authors: R S
authors: RS
authors: Braithwaite
authors: J
authors: J
authors: Conigliaro
authors: M S
authors: MS
authors: Roberts
authors: S
authors: S
authors: Shechter
authors: A
authors: A
authors: Schaefer
authors: K
authors: K
authors: McGinnis
authors: M C
authors: MC
authors: Rodriguez
authors: L
authors: L
authors: Rabeneck
authors: K
authors: K
authors: Bryant
authors: A C
authors: AC
authors: Justice
mesh_terms: D000328:Adult; D000428:Alcohol Drinking / Q000401:mortality*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000401:mortality* / Q000523:psychology; D006801:Humans; D008297:Male; D010349:Patient Compliance / Q000706:statistics & numerical data*; D015995:Prevalence; D012307:Risk Factors; D013997:Time Factors
chemical_list: D019380:Anti-HIV Agents